HLS Therapeutics Inc. (HLS.TO) TSX

5.60

+0.2(+3.70%)

Updated at September 29 11:24AM

Currency In CAD

Valuation

Market Cap86.95M
Enterprise Value135.95M
P/E Ratio-7.99
PEG Ratio-0.5
Price/Sales Ratio2.11
Price/Book Ratio1.81
Enterprise/Revenue2.88
Enterprise/EBITDA10.51

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.27
Operating Margin-0.2

Management Effectiveness

Return On Assets-0.1
Return On Equity-0.21

Income Statement

Revenue56.62M
Revenue/Share1.78
Gross Profit47.62M
EBITDA17.22M
Net Income-19.66M
Diluted EPS-0.62

Balance Sheet

Total Cash12.15M
Total Cash/Share0.38
Total Debt55.57M
Total Debt/Equity0.83
Current Ratio1.09
Book Value Per Share2.1

Price History

52-Week Change43.62
52-Week High5.75
52-Week Low3
Moving Average 50 Days5.26
Moving Average 200 Days4.58

Statistics

Average Volume14,095
Shares Outstanding31.39M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A